LYFIS
- A10 - Antidiabéticos
- GLICLAZID LYFIS prolonged-release tablet 30 mg
- B01 - Agentes antitrombóticos
- HJARTA ASPIRIN gastro-resistant tablet 75 mg
- C07 - Betabloqueantes
- ATENOLOL LYFIS film-coated tablet 25 mg
- ATENOLOL LYFIS film-coated tablet 50 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- ENALAPRIL LYFIS tablet 10 mg
- ENALAPRIL LYFIS tablet 20 mg
- ENALAPRIL LYFIS tablet 5 mg
- G04 - Urológicos
- VIZARSIN film-coated tablet 100 mg
- VIZARSIN film-coated tablet 50 mg
- L02 - Terapia endocrina
- BICALUTAMID LYFIS film-coated tablet 150 mg
- N03 - Antiepilépticos
- ZELTA film-coated tablet 1 000 mg
- ZELTA film-coated tablet 250 mg
- ZELTA film-coated tablet 500 mg
- N04 - Antiparkinsonianos
- OPRYMEA tablet 0.088 mg
- OPRYMEA tablet 0.18 mg
- OPRYMEA tablet 0.7 mg
- N06 - Psicoanalépticos
- ESCITALOPRAM LYFIS film-coated tablet 10 mg
- ESCITALOPRAM LYFIS film-coated tablet 15 mg
- ESCITALOPRAM LYFIS film-coated tablet 20 mg
- ESCITALOPRAM LYFIS film-coated tablet 5 mg
- NIMVASTID capsule, hard 1.5 mg
- NIMVASTID capsule, hard 3 mg
- NIMVASTID capsule, hard 4.5 mg
- NIMVASTID capsule, hard 6 mg
- R06 - Antihistamínicos para uso sistémico
- LORATADIN LYFIS tablet 10 mg